• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[小儿胶质瘤的诊断挑战;分子谱分析在日常诊断中的作用]

[Diagnostic challenges of pediatric gliomas; the role of molecular profiling in everyday diagnostics].

作者信息

Vida Livia, Kereskai László, Kovács Kitti Laura, Kajtár Béla

机构信息

Klinikai Központ, Pécsi Tudományegyetem, Patológiai Intézet, Pécs, Hungary.

出版信息

Magy Onkol. 2024 Dec 10;68(4):299. Epub 2024 Oct 17.

PMID:39657041
Abstract

AIM

This study aims to evaluate the diagnostic challenges and molecular aspects of pediatric gliomas, among the most common brain tumors in children, focusing on improving early detection and personalized treatment strategies.

METHODS

We conducted a comprehensive review of recent literature, examining current diagnostic techniques, including imaging and histopathological analysis, alongside molecular profiling methods such as next-generation sequencing (NGS) and methylation profiling.

RESULTS

The findings highlight significant diagnostic challenges due to the heterogeneity of pediatric gliomas. Molecular profiling has proven essential in identifying key genetic alterations, such as those in the H3F3A and MAPK pathway genes, offering insights into tumor behavior and therapeutic targets.

CONCLUSIONS

Early and accurate diagnosis of pediatric gliomas is hampered by their molecular diversity. Integrating molecular diagnostics with traditional methods is crucial for enhancing diagnostic accuracy and guiding personalized treatment approaches.

摘要

目的

本研究旨在评估儿童胶质瘤(儿童最常见的脑肿瘤之一)的诊断挑战和分子特征,重点是改善早期检测和个性化治疗策略。

方法

我们对近期文献进行了全面综述,研究了当前的诊断技术,包括影像学和组织病理学分析,以及诸如二代测序(NGS)和甲基化分析等分子谱分析方法。

结果

研究结果凸显了由于儿童胶质瘤的异质性而带来的重大诊断挑战。分子谱分析已被证明在识别关键基因改变(如H3F3A和MAPK通路基因中的改变)方面至关重要,这为了解肿瘤行为和治疗靶点提供了线索。

结论

儿童胶质瘤的分子多样性阻碍了其早期和准确诊断。将分子诊断与传统方法相结合对于提高诊断准确性和指导个性化治疗方法至关重要。

相似文献

1
[Diagnostic challenges of pediatric gliomas; the role of molecular profiling in everyday diagnostics].[小儿胶质瘤的诊断挑战;分子谱分析在日常诊断中的作用]
Magy Onkol. 2024 Dec 10;68(4):299. Epub 2024 Oct 17.
2
Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.儿童和青少年脑胶质瘤:具有潜在预后和治疗影响的分子改变研究。
J Cancer Res Clin Oncol. 2022 Jan;148(1):107-119. doi: 10.1007/s00432-021-03813-1. Epub 2021 Oct 9.
3
[Classification of gliomas. Current progress and perspectives].[胶质瘤的分类。当前进展与展望]
Nervenarzt. 2015 Jun;86(6):672, 674-6, 678-80, passim. doi: 10.1007/s00115-014-4223-3.
4
Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel.使用胶质瘤定制基因panel的下一代测序技术对胶质瘤进行分子诊断
Brain Pathol. 2017 Mar;27(2):146-159. doi: 10.1111/bpa.12367. Epub 2016 Apr 19.
5
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas.全基因组 DNA 甲基化谱分析在小儿型弥漫性神经胶质瘤中的应用。
Brain Tumor Pathol. 2023 Apr;40(2):56-65. doi: 10.1007/s10014-023-00457-6. Epub 2023 Apr 1.
6
Diagnostic utility of genetic alterations in distinguishing IDH-wildtype glioblastoma from lower-grade gliomas: Insight from next-generation sequencing analysis of 479 cases.基因改变在鉴别 IDH 野生型胶质母细胞瘤与低级别胶质瘤中的诊断效用:来自 479 例病例的下一代测序分析的见解。
Brain Pathol. 2024 Sep;34(5):e13234. doi: 10.1111/bpa.13234. Epub 2024 Jan 12.
7
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.对 282 例儿童低级别和高级别神经胶质瘤的全面基因组分析揭示了基因组驱动因素、肿瘤突变负担和超突变特征。
Oncologist. 2017 Dec;22(12):1478-1490. doi: 10.1634/theoncologist.2017-0242. Epub 2017 Sep 14.
8
Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations.将大型下一代测序面板整合到胶质细胞瘤的临床诊断中,为从 FFPE 组织或涂片制备物进行分类提供了一个全面的平台。
J Neuropathol Exp Neurol. 2019 Mar 1;78(3):257-267. doi: 10.1093/jnen/nly130.
9
Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas.利用分子生物学进行儿童低级别胶质瘤的诊断和靶向治疗。
Future Oncol. 2016 Jun;12(12):1493-506. doi: 10.2217/fon-2016-0039. Epub 2016 Apr 13.
10
Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics.用于常规胶质瘤诊断的专用下一代测序 panel 的临床评估。
Acta Neuropathol Commun. 2018 Nov 23;6(1):126. doi: 10.1186/s40478-018-0633-y.